Abstract:Innate immunity is critical for the early detection and elimination of viral invasion. Extracellular signals are crucial for host resistance; however, how extracellular factors prepare the innate immunity for rapid antiviral response remains elusive. Here, we find that serum deprivation largely restricts the innate antiviral responses to RNA and DNA viruses. When serum is supplied, serine/threonine-protein kinase 38-like (STK38L), induced by serum response factor (SRF), phosphorylates IRF3 at Ser303, which prevents IRF3 from proteasome-mediated degradation in the rest state (non-infected), and ensures that enough IRF3 is called in the primed state (infected). STK38L-deficient mice exhibit compromised innate antiviral responses and elevated viral proliferation and mortality. Moreover, lysophosphatidic acid (LPA) or sphingosine 1-phosphate (S1P), the crucial activators of SRF, rescue immunosuppression caused by serum deprivation. These findings identify the SRF-STK38L-IRF3 axis as a novel mechanism that maintains the host in a pro-active state when not infected, which ensures the rapid immune response against virus. Introduction Type I interferon (IFN) is a sophisticated early line of defense used to combat viral infections. Mammalian cells sense viral invasion by germline-encoded pattern-recognition receptors, including Toll-like receptors (TLRs), acid-inducible gene I (RIG-I)-like receptors (RLRs), and several cytosolic DNA sensors. The RNA receptor RIG-I, melanoma differentiation-associated gene 5 (MDA5), and DNA sensors including cyclic GMP-AMP synthase (cGAS) recognize nucleic acids in the cytoplasm and then recruit their adaptor proteins, mitochondrial antiviral signaling protein (MAVS), and stimulator of IFN genes (STING) to initiate a series of signaling cascades that converge at the protein TANK-binding kinase 1 (TBK1) and IκB kinase ε (IKKε). TBK1 and IKKε phosphorylate and activate transcription factor IFN regulatory factor 3 (IRF3), resulting in the transcription of IFN-β as an initial response and subsequently switching to IRF7-induced IFN-α production. Type I IFNs (IFN-α and IFN-β), sequentially, induce the synthesis of a large number of antiviral IFN-stimulated genes (ISGs) and play a central role in intracellular antiviral defense. 1 Fischer S. Pattern recognition receptors and control of innate immunity: role of nucleic acids. Curr. Pharm. Biotechnol. 2018; 19 : 1203-1209 https://doi.org/10.2174/138920112804583087 Crossref PubMed Scopus (23) Google Scholar , 2 Ma Z. Damania B. The cGAS-STING defense pathway and its counteraction by viruses. Cell Host Microbe. 2016; 19 : 150-158 https://doi.org/10.1016/j.chom.2016.01.010 Full Text Full Text PDF PubMed Scopus (218) Google Scholar , 3 Marié I. Durbin J.E. Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 1998; 17 : 6660-6669 https://doi.org/10.1093/emboj/17.22.6660 Crossref PubMed Google Scholar Growing evidence suggests that nutritional status has important implications for host resistance to infection. 4 Wu D. Lewis E.D. Pae M. Meydani S.N. Nutritional modulation of immune function: analysis of evidence, mechanisms, and clinical relevance. Front. Immunol. 2018; 9 : 3160 https://doi.org/10.3389/fimmu.2018.03160 < -Abstract Truncated-

Type I interferon, induced by adenovirus or adenoviral vector infection, regulates the cytokine response to LPS in a macrophage type-specific manner

Differential Interferon-Α Subtype Induced Immune Signatures Are Associated with Suppression of SARS-CoV-2 Infection.

Type I interferon regulates interleukin-1beta and IL-18 production and secretion in human macrophages

IFN-τ Alleviates Lipopolysaccharide-Induced Inflammation by Suppressing NF-κB and MAPKs Pathway Activation in Mice

Dampening of ISGylation of RIG-I by ADAP regulates type I interferon response of macrophages to RNA virus infection

Effects of toll-like receptor agonists and SARS-CoV-2 antigens on interferon (IFN) expression by peripheral blood CD3+ T cells from COVID-19 patients

Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity

Leptospiral Lipopolysaccharide-Induced Expression of Inflammatory Cytokines and Mononuclear-Mac-rophage Infiltration in Viscera of Mice with Leptospira Interrogans Infection

Type I interferon governs immunometabolic checkpoints that coordinate inflammation during infection

Absence of c-Maf and IL-10 enables Type I IFN enhancement of innate responses to low-dose LPS in alveolar macrophages

Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden

Differential interferon-α subtype immune signatures suppress SARS-CoV-2 infection

Traces of bacterial lipopolysaccharide suppress IFN-gamma-induced nitric oxide synthase gene expression in primary mouse macrophages.

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections

Type I interferon governs immunometabolic checkpoints that coordinate inflammation during Staphylococcal infection

LPA maintains innate antiviral immunity in a pro-active state via STK38L-mediated IRF3 Ser303 phosphorylation

Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19

IFN-λ uniquely promotes CD8 T cell immunity against SARS-CoV-2 relative to type I IFN

COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs

Transforming growth factor beta 1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages